메뉴 건너뛰기




Volumn 58, Issue 1, 2010, Pages 76-78

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children

Author keywords

Coats' disease; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; APTAMER; BEVACIZUMAB; MONOCLONAL ANTIBODY; PEGAPTANIB; VASCULOTROPIN A;

EID: 73849109765     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.58480     Document Type: Article
Times cited : (47)

References (6)
  • 1
    • 0035207359 scopus 로고    scopus 로고
    • Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation
    • Cahill M, O'Keefe M, Acheson R, Mulvihill A, Wallace D, Mooney D. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation. Acta Ophthalmol Scand 2001;79:596-602.
    • (2001) Acta Ophthalmol Scand , vol.79 , pp. 596-602
    • Cahill, M.1    O'Keefe, M.2    Acheson, R.3    Mulvihill, A.4    Wallace, D.5    Mooney, D.6
  • 2
    • 0036480152 scopus 로고    scopus 로고
    • Review: Coats disease: The 2001 LuEsther T. Mertz lecture
    • Shields JA, Shields CL. Review: Coats disease: The 2001 LuEsther T. Mertz lecture. Retina 2002;22:80-91.
    • (2002) Retina , vol.22 , pp. 80-91
    • Shields, J.A.1    Shields, C.L.2
  • 3
    • 33845745774 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
    • Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
    • (2006) Retina , vol.26 , pp. 999-1005
    • Haritoglou, C.1    Kook, D.2    Neubauer, A.3    Wolf, A.4    Priglinger, S.5    Strauss, R.6
  • 4
    • 34548022138 scopus 로고    scopus 로고
    • Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium
    • Sun Y, Jain A, Moshfeghi DM. Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 2007;245:1387-1388
    • (2007) Graefes Arch Clin Exp Ophthalmol , vol.245 , pp. 1387-1388
    • Sun, Y.1    Jain, A.2    Moshfeghi, D.M.3
  • 5
    • 42049110754 scopus 로고    scopus 로고
    • Management of Coats disease with bevacizumab in 2 patients
    • Venkatesh P, Mandal S, Garg S. Management of Coats disease with bevacizumab in 2 patients. Can J Ophthalmol 2008;43:245-246
    • (2008) Can J Ophthalmol , vol.43 , pp. 245-246
    • Venkatesh, P.1    Mandal, S.2    Garg, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.